Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
Justine Habault(New York University), Jean‐Luc Poyet(Centre National de la Recherche Scientifique)
Cited by 281
Related Papers
The anticancer peptide RT53 induces immunogenic cell death
|PLoS ONE|2018|56
A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer
|Molecular Cancer Therapeutics|2023|4